Teva Pharmaceutical Industries (TEVA) Divestments (2020 - 2026)
Teva Pharmaceutical Industries' (TEVA) quarterly Divestments came in at $4.0 million in Q2 2026, down 55.56% YoY from $9.0 million in Q2 2025, and down 90.48% on a QoQ basis from $42.0 million in Q1 2026.
Teva Pharmaceutical Industries (TEVA) Divestments (2020 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 7 years of Divestments data on file, last reported at $4.0 million in Q2 2026.
- Quarterly Divestments fell 55.56% year-over-year to $4.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $54.0 million (down 20.59% YoY) and the FY2025 annual result came in at $34.0 million, down 20.93% from the prior year.
- Divestments retreated to $4.0 million in Q2 2026, from $42.0 million in the prior quarter.
- In the past five years, Divestments ranged from a high of $56.0 million in Q2 2023 to a low of $1.0 million in Q2 2024.
- A 5-year average of $17.3 million and a median of $10.0 million in 2023 frame the typical range for Divestments.
- Annual changes were most pronounced in 2024 — Divestments tumbled 98.21% — and 2025, when it surged 800.0%.
- Tracing TEVA's Divestments over 5 years: stood at $23.0 million in 2022, then plunged by 56.52% to $10.0 million in 2023, then slumped by 60.0% to $4.0 million in 2024, then surged by 100.0% to $8.0 million in 2025, then slumped by 50.0% to $4.0 million in 2026.
- The last three Divestments figures came in at $4.0 million (Q2 2026), $42.0 million (Q1 2026), and $8.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 4.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 65.64 Mn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.00 Mn |
| Mar 31, 2026 | 42.00 Mn |
| Sep 30, 2025 | 8.00 Mn |
| Jun 30, 2025 | 9.00 Mn |
| Mar 31, 2025 | 17.00 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Sep 30, 2024 | 38.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Sep 30, 2023 | 10.00 Mn |
| Jun 30, 2023 | 56.00 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 23.00 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 18.00 Mn |
| Mar 31, 2022 | 25.00 Mn |
| Dec 31, 2021 | 42.00 Mn |
| Sep 30, 2021 | 15.00 Mn |
| Jun 30, 2021 | 116.00 Mn |
| Mar 31, 2021 | 138.00 Mn |
| Dec 31, 2020 | 13.00 Mn |